投资逻辑： 近期医疗器械领域政策与产业动态密集，创新支持与国际化布局同步推进。国家药监局批准创新医疗器械持续增加， 优先审评目录聚焦脑机接口、高端影像设备等核心领域。同时医保局为手术机器人等相关医疗服务项目建立新的收费 标准，创新产品入院速度有望进一步提升。脑机接口、手术机器人、智能诊断、生物材料等多赛道迎来发展机遇，行 业迈入以临床价值为核心的新发展阶段，国产头部企业将迎来加速发展机遇。 创新药：赛诺菲/再生元的度普利尤单抗获 FDA 批准成为全球首款 AFRS 治疗药物，基于 LIBERTY-AFRS-AIMSIII 期临 床数据，该药在鼻窦混浊评分、鼻息肉缩小及嗅觉改善等关键终点上显著优于安慰剂，安全性与已获批的 CRSwNP 适 应症一致，为这一高复发率疾病提供了首个靶向 2 型炎症的非手术替代方案。 生物制品： 2026 年 2 月 24 日，联邦制药与诺和诺德联合发布 GLP-1/GIP/GCG 三靶点受体激动剂（三激动剂）UBT251 中国 II 期临床研究的主要结果，治疗 24 周后，UBT251 治疗组的平均体重降幅最高达 19.7%（-17.5kg）。全球已有多 款 GLP-1 三靶药物进 ...

本周观点 相关标的 相关标的：东阳光、寒武纪、海光信息、网宿科技、润泽科技、协创数据、华丰科技、大位科技、神州数码、润建股 份、科华数据、中芯国际、华虹半导体、中科曙光、禾盛新材、奥飞数据、优刻得、首都在线、云赛智联、瑞晟智能、 浪潮信息、潍柴重机、欧陆通等。 风险提示 行业竞争加剧的风险；技术研发进度不及预期的风险；特定行业下游资本开支周期性波动的风险。 敬请参阅最后一页特别声明 1 开年即"熔断"，从 Seedance 排队到 GLM5"交错思维"。1）一方面，Seedance 2.0 节后出现长时间排队现 象，印证视频生成对算力的高强度消耗。基于 DiT 架构的视频推理对显存带宽与并发计算提出更高要求，头部厂 商储备面临短期压力，供给缺口正从逻辑推演转化为实质性紧张。2）另一方面，智谱 GLM-5 明确"交错思维 （Interleaved Thinking）"机制，开启"以算力换智能"新范式。海量隐式计算（Hidden Tokens）带来单次推理 消耗的乘数效应。 训推共振，算力需求极速释放。我们判断，2026 年将是中国算力需求从"云端训练"向"训练+推理"双轮驱动 转型的关键之年，算力缺口将在更多模 ...

统计口径误差。数据统计大多为抽样，恐与现实情况有些许出入。 本周（2 月 15 日至 2 月 28 日），国金证券固收基本面监测体系中,共有 45 个高频指标更新。其中我们对绝对值指标计 算当月同比，对百分比指标计算月均值，然后针对债市做定性判断。结果显示：总体上，"利好"与"利空"指标个 数分别为 18 个与 27 个。其中，"利好"主要体现在粗钢产量、多数行业开工率、商品房成交面积、消费(轻纺成交)、 出行（市内）、工业品价格等方面，"利空"主要体现在耗煤、商品房成交价格&土地成交量价、消费（集装箱吞吐量、 快递、失业金搜索指数、票房）、出行（远距离）、出口、旅游消费价格、及多数农产品价格等方面。 本周（2 月 15 日至 2 月 28 日），利率十大同步指标释放的信号中，"利好"和"利空"各自占比 5/10；较上周的变化 有：企业中长贷余额增速、美元指数发出"利好"信号。 具体地：①企业中长贷余额增速为 7.4%，低于前值 7.9%，属性"利好"；②建材综合指数为 114.0，低于前值 115.3， 属性"利好"；③BCI：企业招工前瞻指数为 56.3%，高于前值 55.8%，属性"利空"；④失业金领取 ...

5 下游需求不及预期；海外政策变化；竞争加剧；限售股解禁。 事件 2 月 27 日，公司发布 2025 年度业绩快报，全年预计实现收入 10.71 亿元，同比增长 44.9%；全年预计实现归母净利润 1.75 亿元，同 比增长 21.8%。单 Q4 预计实现收入 3.34 亿元，同比增长 46.8%； 单 Q4 预计实现归母净利润 0.50 亿元，同比增长 30%。 经营分析 业绩快报符合预期。根据业绩快报，公司利润大幅增长主要原因为 专注主业，持续加大研发投入，巩固核心技术及产品。公司工业 X 射线源实现全谱系覆盖，微焦点射线源实现大规模出货，纳米级开 管射线源以及大功率射线源顺利实现产业化，AI 智能检测软件、 3D/CT 检测技术等领域实现突破，产品市场竞争力得到提升，新签 订单实现大幅度增长。 收购整合持续推进。2025 年公司顺利落地多项重大并购，2025 年 6 月 14 日，公司公告收购珠海九源 55%股份，后者主营高端新能 源电能变换设备及检测产品，公司凭借此次收购进入电池电性能 检测赛道。2026 年 1 月 10 日，公司公告落地收购新加坡 SSTI66% 的股份，后者是全球极少数的高端半 ...

2026 年 02 月 26 日 香港交易所（00388.HK） 买入（维持评级） 港股公司点评 证券研究报告 业绩略超预期，多市场成交额创新高 业绩简评 2026 年 2 月 26 日，香港交易所发布 2025 年业绩报告。2025 香港 交易所实现营业收入（收入及其他收益）291.61 亿港元，同比增 长 30%；归母净利润 177.54 亿港元，同比增长 36%。25Q4 归母净 利润 43.35 亿港元，同比增长 15%，环比减少 12%，主要是因为 25Q4 交投活跃度小幅降低。分业务条线来看，2025 现货、衍生品、商 品 、 数 据 及 连 接 、 公 司 项 目 收 入 同 比 增 速 分 别 为 56%/11%/14%/7%/17%，占营收比重分别为 50%/24%/11%/8%/7%。分 收费模式来看，交易及交易系统使用费、联交所上市费、结算及 交收费、存管托管及代理人服务费、市场数据费、投资收益同比 增 速 分 别 为 44%/21%/49%/31%/8%/4% ， 占 营 收 比 重 分 别 为 35%/6%/24%/5%/4%/18%。 经营分析 交易费：（1）现货市场：2025 年 ...

风险提示 国金·月度金股 3 月： | 代码 | 简称 | 行业 | 收盘价(元) | 流通市值 | EPS(元) | | | PE | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 2026/2/26 | 亿元 | 2025E | 2026E | 2025E | 2026E | | 000807.SZ | 云铝股份 | 工业金属 | 30.99 | 1074.71 | 1.79 | 2.17 | 17.36 | 14.31 | | 002493.SZ | 荣盛石化 | 炼化及贸易 | 15.27 | 1429.61 | 0.17 | 0.32 | 91.44 | 48.48 | | 603308.SH | 应流股份 | 通用设备 | 73.06 | 496.10 | 0.66 | 0.92 | 111.37 | 79.41 | | 601211.SH | 国泰海通 | 证券Ⅱ | 18.97 | 2560.36 | 1.62 | 1.42 | 11.71 | 13.36 | | 600642.SH | 申能股份 | 电力 | ...

Investment Rating - The report maintains a "Buy" rating for the company, with projected PE ratios of 42, 34, and 27 for the years 2025, 2026, and 2027 respectively [4] Core Insights - The company is expected to achieve a revenue of 2.584 billion RMB in 2025, representing a year-on-year growth of 25%. The net profit attributable to the parent company is projected to be 821 million RMB, up 22% year-on-year [2] - The company's core product, PFA, has been well-promoted, leading to synergistic growth. The company emphasizes cost control, focusing R&D and sales expenses on market promotion, clinical validation, and next-generation product development [2] - The product pipeline is continuously advancing, with new products in coronary and peripheral business expected to enter a harvest phase. The company is actively conducting various marketing activities to enhance product coverage and admission rates [3] Financial Projections - The projected net profits for the company from 2025 to 2027 are 821 million RMB, 1.009 billion RMB, and 1.290 billion RMB, reflecting growth rates of 22%, 23%, and 28% respectively [4] - Revenue growth rates are expected to be 25.08% in 2025, 22.52% in 2026, and 26.85% in 2027 [9] - The diluted earnings per share are forecasted to be 5.818 RMB in 2025, 7.157 RMB in 2026, and 9.147 RMB in 2027 [9]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected price increase of over 15% in the next 6-12 months [4]. Core Insights - The company reported a revenue of $68.127 billion for FY26Q4, representing a year-on-year growth of 73%. The GAAP and Non-GAAP gross margins were 75.0% and 75.2%, respectively, with net profits of $42.96 billion and $39.55 billion, reflecting year-on-year increases of 94% and 79% [2]. - For FY27Q1, the company guides revenue to be around $78 billion (±2%), excluding data center revenue from China, with expected gross margins of 74.9% and 75.0% for GAAP and Non-GAAP, respectively [2]. - The data center revenue reached $62.314 billion in FY26Q4, up 75% year-on-year, with network revenue contributing approximately $11 billion. The company is set to commercialize the Vera Rubin CPU in the second half of the year, which is crucial for AI applications [3]. - The company anticipates diversification in its customer base, moving beyond the top five cloud service providers that currently account for over 50% of its revenue. Strategic investments, such as in Anthropic, aim to expand its AI ecosystem [3]. - The company is positioned as a leader in AI chips, benefiting from ongoing AI development. The product iterations and the high moat created by the CUDA platform are expected to maintain its competitive advantage [4]. - Projected net profits for FY27, FY28, and FY29 are $217.6 billion, $307.4 billion, and $381.1 billion, respectively, indicating strong growth potential [4]. Financial Summary - The company’s revenue is projected to grow from $215.938 billion in FY26 to $401.342 billion in FY27, reflecting a growth rate of 85.9% [9]. - The net profit is expected to increase from $120.067 billion in FY26 to $217.582 billion in FY27, with a growth rate of 81.2% [10]. - The earnings per share (EPS) is forecasted to rise from $4.94 in FY26 to $8.95 in FY27 [9].

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for future performance [4]. Core Insights - The company reported a revenue of $68.127 billion for FY26Q4, representing a year-over-year increase of 73%. The GAAP and Non-GAAP gross margins were 75.0% and 75.2%, respectively, with net profits of $42.96 billion and $39.55 billion, reflecting increases of 94% and 79% year-over-year [2]. - For FY27Q1, the company guides revenue expectations at $78 billion (±2%), excluding data center revenue from China, with projected gross margins of 74.9% and 75.0% for GAAP and Non-GAAP, respectively [2]. - The data center revenue grew rapidly, reaching $62.314 billion in FY26Q4, a 75% increase year-over-year, with network revenue contributing approximately $11 billion. The company plans to commercialize the Vera Rubin CPU in the second half of the year, which is expected to enhance performance in data processing and AI applications [3]. - The company anticipates diversifying its customer base beyond the top five cloud service providers, which currently account for over 50% of its revenue. Strategic investments, such as in Anthropic, aim to expand the AI ecosystem around the company's CUDA platform [3]. - The company is positioned as a leader in AI chips, benefiting from ongoing AI development. The product lineup continues to evolve, with the Vera Rubin expected to be a significant contributor to revenue growth. The company is well-positioned in networking, computing power, and software ecosystems [4]. Financial Projections - The company is projected to achieve net profits of $217.6 billion, $307.4 billion, and $381.1 billion for FY27, FY28, and FY29, respectively, indicating strong growth potential [4]. - Revenue forecasts for FY27, FY28, and FY29 are $401.342 billion, $562.932 billion, and $692.407 billion, respectively, with growth rates of 85.9%, 40.3%, and 23.0% [9].

1. Report's Investment Rating for the Industry No information provided in the content. 2. Core View of the Report The report tracks the supply and trading of local government bonds, covering the issuance rhythm, pricing, regional differences in the primary market, and trading characteristics in the secondary market. It shows that the issuance and trading of local government bonds have certain regional characteristics, and their performance in the secondary market lags behind that of treasury bonds and high - grade credit bonds [3][4]. 3. Summary According to the Directory 3.1 Primary Supply Rhythm - During the week before the festival (2026.2.9 - 2026.2.13), local government bonds issued a total of 322.136 billion yuan, including 195.074 billion yuan of new special bonds and 44.645 billion yuan of refinancing special bonds. The main investment areas of special bond funds are "ordinary/project income" and "replacing implicit debts". As of now, about 429.07 billion yuan of special refinancing special bonds have been issued in February, accounting for 37.05% of the local bond issuance scale in that month [3][10]. - In terms of issuance pricing, the issuance rates of 10 - year, 20 - year, and 30 - year local bonds decreased by 0.8BP, 2.2BP, and 2.8BP respectively. The spread between new bonds and treasury bonds of the same term was slightly compressed, with a decline of less than 1bp, but the spread of the 30 - year variety was still similar to the reading in mid - January [3][17]. - Regionally, Hebei and Jiangxi were the main regions for local bond issuance in February. Among the regions with large issuance scales, the proportion of local bonds with a term of over 10 years issued in Henan and Zhejiang exceeded 80%, and the average coupon rates of the two regions were above 2.3%. In particular, the issuance rate of local bonds in Henan reached 2.4% [3][19]. 3.2 Secondary Trading Characteristics - The increase of local bonds was less than that of treasury bonds of the same term. During the week before the festival, the indices of 7 - 10 - year and over 10 - year local bonds rose by 0.13% and 0.16% respectively. With the entry of funds holding bonds for the festival, treasury bonds with stronger liquidity were easier to obtain, and long - term credit bonds were also favored by some institutions due to their absolute returns. Local bonds failed to outperform treasury bonds of the same term and high - grade credit bonds [4][23]. - In terms of different provinces, government bonds in Jiangsu and Guangdong were actively traded, and the trading volumes in Jiangsu, Jiangxi, and Henan increased by more than 40 transactions compared with the previous period. In addition, in regions where the average yield was above 2.25%, the trading terms were mostly extended to over 20 years. Notably, the average trading yields of local bonds in Henan and Guangxi reached 2.27% and 2.35% respectively, with average terms of 19.9 years and 18.8 years [4][23].